Market Cap ₹83 Cr.
Stock P/E 2.2
P/B 1.4
Current Price ₹64
Book Value ₹ 46.9
Face Value 10
52W High ₹94.5
Dividend Yield 0%
52W Low ₹ 35.2
Vels Film International Ltd, incorporated in 2019 and headquartered in Chennai, Tamil Nadu, is a prominent player in the South Indian film industry. Founded by Dr. Ishari K. Ganesh, the company focuses on producing feature films across various languages and selling film rights. As a member of the South Indian Film Chamber of Commerce, Vels Film International has established itself as a significant contributor to the Tamil film industry, which ranks as the third-largest in India. Since its inception, the company has produced several notable films, including Mookuthi Amman, Kutty Story, Sumo, Joshua Imai Pol Kaakha, and Vendhu Thanindhathu Kaadu. Upcoming projects in its pipeline feature titles like Singapore Salon, Corona Kumar, and Chutney Sambar.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 27 | 60 | 40 | 69 | |
| Other Income | 1 | 1 | 0 | 23 | |
| Total Income | 27 | 61 | 40 | 92 | |
| Total Expenditure | 18 | 52 | 54 | 69 | |
| Operating Profit | 10 | 9 | -15 | 23 | |
| Interest | 3 | 4 | 7 | 10 | |
| Depreciation | 1 | 2 | 13 | 17 | |
| Exceptional Income / Expenses | 0 | 0 | -12 | 46 | |
| Profit Before Tax | 5 | 3 | -47 | 42 | |
| Provision for Tax | 2 | 2 | -4 | 4 | |
| Profit After Tax | 3 | 1 | -43 | 38 | |
| Adjustments | 0 | 1 | 7 | 5 | |
| Profit After Adjustments | 3 | 1 | -36 | 43 | |
| Adjusted Earnings Per Share | 3.6 | 1.1 | -28.2 | 33.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 73% | 37% | 0% | 0% |
| Operating Profit CAGR | 0% | 32% | 0% | 0% |
| PAT CAGR | 0% | 133% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 25% | NA% | NA% | NA% |
| ROE Average | 98% | -7% | -1% | -1% |
| ROCE Average | 37% | 6% | 8% | 8% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 19 | 54 | 18 | 61 |
| Minority's Interest | -0 | -1 | -8 | 0 |
| Borrowings | 48 | 54 | 52 | 47 |
| Other Non-Current Liabilities | -0 | -0 | 0 | 4 |
| Total Current Liabilities | 55 | 80 | 173 | 89 |
| Total Liabilities | 122 | 188 | 236 | 201 |
| Fixed Assets | 28 | 28 | 116 | 0 |
| Other Non-Current Assets | 11 | 53 | 5 | 35 |
| Total Current Assets | 83 | 107 | 114 | 166 |
| Total Assets | 122 | 188 | 236 | 201 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 1 | 8 | 6 |
| Cash Flow from Operating Activities | 31 | -38 | 21 | 32 |
| Cash Flow from Investing Activities | -87 | -42 | -53 | 67 |
| Cash Flow from Financing Activities | 57 | 87 | 31 | -82 |
| Net Cash Inflow / Outflow | 1 | 7 | -1 | 17 |
| Closing Cash & Cash Equivalent | 1 | 8 | 6 | 24 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.56 | 1.11 | -28.22 | 33.34 |
| CEPS(Rs) | 4.94 | 2.1 | -23.08 | 42.66 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 19.78 | 41.81 | 13.59 | 46.93 |
| Core EBITDA Margin(%) | 34.15 | 13.63 | -37.58 | -0.38 |
| EBIT Margin(%) | 30.82 | 12.1 | -100.33 | 75.83 |
| Pre Tax Margin(%) | 18.31 | 4.62 | -117.71 | 61.5 |
| PAT Margin (%) | 12.22 | 0.87 | -108.65 | 55.44 |
| Cash Profit Margin (%) | 17.64 | 4.53 | -75.35 | 80.1 |
| ROA(%) | 2.67 | 0.34 | -20.3 | 17.44 |
| ROE(%) | 17.31 | 1.44 | -120.14 | 97.56 |
| ROCE(%) | 11.75 | 6.23 | -24.28 | 37.06 |
| Receivable days | 259.43 | 65.46 | 45.8 | 58.27 |
| Inventory Days | 499.96 | 275.49 | 565.79 | 458.34 |
| Payable days | -287.08 | -237.55 | -239.63 | -105.78 |
| PER(x) | 0 | 87.18 | 0 | 2.22 |
| Price/Book(x) | 0 | 2.32 | 4.51 | 1.58 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 2.25 | 3.78 | 5.54 | 1.87 |
| EV/Core EBITDA(x) | 6.21 | 23.98 | -14.97 | 5.6 |
| Net Sales Growth(%) | 0 | 125.09 | -34.02 | 73.86 |
| EBIT Growth(%) | 0 | -11.64 | -647.22 | 231.4 |
| PAT Growth(%) | 0 | -83.89 | -8296.55 | 188.71 |
| EPS Growth(%) | 0 | -68.75 | -2636.23 | 218.15 |
| Debt/Equity(x) | 2.72 | 2.02 | 8.35 | 0.94 |
| Current Ratio(x) | 1.5 | 1.33 | 0.66 | 1.85 |
| Quick Ratio(x) | 0.84 | 0.66 | 0.26 | 0.69 |
| Interest Cover(x) | 2.46 | 1.62 | -5.77 | 5.29 |
| Total Debt/Mcap(x) | 0 | 0.87 | 1.85 | 0.59 |
| # | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Promoter | 73.6 | 73.6 | 73.6 | 73.6 | 73.53 |
| FII | 0.78 | 0 | 0 | 0 | 0 |
| DII | 1.69 | 0 | 0.27 | 0.26 | 0.07 |
| Public | 23.93 | 26.4 | 26.13 | 26.14 | 26.4 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Promoter | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
| FII | 0.01 | 0 | 0 | 0 | 0 |
| DII | 0.02 | 0 | 0 | 0 | 0 |
| Public | 0.31 | 0.34 | 0.34 | 0.34 | 0.34 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
